India APAC
FDF / DRUG PRODUCTS NUTRACEUTICALS SERVICES OLIGONUCLEOTIDES PARTICLE ENGINEERING in APAC
An USFDA approved API & Intermediate Manufacturing facility
About the plant
Srikar Labs Pvt Ltd a leading manufacturer and reliable supplier of Active Pharmaceutical Ingredients (APIs) and Intermediates , based in Hyderabad & Visakhapatnam.
An USFDA audited manufacturing facility, capacity of 160 KL
We understand the critical importance of secure, high-quality, and cost-effective raw material sourcing for your organization to your products. We specialize in supply of a broad portfolio of APIs, including Cardiovascular APIs, Anti-diabetic APIs and many more..
Certifications
- ISO
- FDA (cGMP)
Activity
- FDF / DRUG PRODUCTS, NUTRACEUTICALS, SERVICES, OLIGONUCLEOTIDES, PARTICLE ENGINEERING, Granules / Pellets, Powders, ASOs (Antisense oligonucleotides), siRNA, miRNA, PMOs manufacturing
Features
- Uses: Commercial (Phase IV), Human, Veterinary
- Toxicity (OEB classification): N/A
- Controlled substance: N/A
- BSL: 1, 2, 3, 4
- Therapeutic areas: (A) Digestive tract and metabolism, (B) Blood and blood forming organs, (C) Cardiovascular system, (D) Dermatologicals, (G) Genito urinary system and sex hormones, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V06) Nutrients, (V01) Allergens
- Markets: DIGEMID (Peru), COFEPRIS (Mexico), INVIMA (Colombia), ISP (Chile), FDA (USA), EMA (EU), PMDA (Japan), CDSCO (India), NMPA (China), EDE (UAE), ANVISA (Brazil), ANMAT (Argentina), MFDS (South Korea), Russian Health Authorities, SFDA (Saudi Arabia)
Batch Size / Reactor
- Small, Medium, Large
Services
- Manufacturing services, Tech transfer, Pilot plant, Research batches, Engineering batches, Scale-up, Pilot batches, Registration batches, Batch records, Clean room rental
